Surgery Partners owns and operates a network of ambulatory surgery centers and surgical hospitals across the United States. It partners with physicians and health systems to deliver outpatient and short-stay surgical care outside traditional inpatient hospitals. Services span many specialties, including orthopedics, ophthalmology, gastroenterology, and pain management. The model targets patients, surgeons, and payers seeking lower-cost, high-volume procedural settings.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 826.2 | — | -2.5 | — |
| Q3 2025 | 821.5 | — | -22.7 | — |
| Q4 2025 | 885 | — | -15 | — |
| Q1 2026 | 810.9 | — | -35.9 | — |
| Q2 2026 | 848.9 | 2.8% | -15 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: GeneDx Holdings Corp. (WGS), National Energy Services Reunited Corp. (NESR), BioLife Solutions, Inc. (BLFS), ADARx Pharmaceuticals, Inc. (ADRX), Xeris Biopharma Holdings, Inc. (XERS), German American Bancorp, Inc. (GABC)